InvestorsHub Logo

leavetheguntakethecannolis

02/03/23 5:38 PM

#396176 RE: farrell90 #396175

Awesome find Farrell. Thanks again for your significant contributions. Have a great weekend.
Bullish
Bullish

SitTight

02/03/23 5:47 PM

#396177 RE: farrell90 #396175

I googled "Subhash Dhawan", the applicant's name. He's got a very interesting profile.

LinkedIn profile

25 years at the FDA. His latest position was Senior Investigator and Chief, Viral Immunology Section, Laboratory of Molecular Virology, FDA!

That man knows his stuff. How did he hear about Brilacidin? What did his old collegues tell him about Brilacidin? Intriguing!

CallMeCrazy

02/04/23 8:32 AM

#396192 RE: farrell90 #396175

Could this invention flow from NIH's Brilicidin work?

NIH has an office in Gaithersburg, Maryland and the "swab" inventor, Subhash Dhawan, is also from Gaithersburg. Thus, it seems reasonable to assume she is a government scientist, who has been involved with brilicidin research or, at the very least, she's aware of the brilicidin research.

I also wonder if she came up with this "swab" idea after seeing the high-efficacy of the brilicidin/remdesivir combo?

In terms of a Sars-Cov2 prophylactic, the evidence suggest that her "swab" should have brilicidin on one end and remdesivir on the other.

There is also the possibility of different types of "swabs" for different types of viral afflictions.

This could be a "godsend" for China, Third World and even more advanced countries.

Great find Farrell90!

https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20230036304

xoc

02/04/23 12:53 PM

#396210 RE: farrell90 #396175

The swab including brilacidin might slso make a great prophylactic as previously discussed for nasal sprays using other agents

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313533/